纵横研报
Ticker Detail

603716.SHG

¥14.65+3.75% 塞力医疗 Diagnostics & Research
00Reports China 医疗健康
Wuhan Thalys Med Tech Co Ltd
医疗健康 · 诊断与研究

Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. It offers automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. The company also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.

MARKET 市值 3.24B CNY 52W ¥12.92 – ¥38.12 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -36.8% ROE -21.5% 营业利润率 -6.2% 净利润率 -21.7%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制